Patents by Inventor Guoxun Chen

Guoxun Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEHICLE-MOUNTED LIBRARY WORKSTATION
    Publication number: 20130112725
    Abstract: The present disclosure discloses a vehicle-mounted library workstation, comprising a shell, on which a books and disks identifying module and a reader card identifying module are arranged; wherein the books and disks identifying module comprises a book reading antenna and a book reader for driving the book reading antenna, decoding and transferring data scanned by the book reading antenna; the book reader and reader card reading device are RFID tags readers; the vehicle-mounted library workstation being connected to a computer while working, wherein the computer controls the reader card identifying module to collect information of the reader card, controls the books and disks identifying module to collect information of the books and disks, and processes the information of the reader card and information of the books or disks to finish operations of borrowing and returning books.
    Type: Application
    Filed: June 6, 2012
    Publication date: May 9, 2013
    Inventors: Tao Luo, Jinghong Yang, Yongdong Wang, Cuihong Wu, Zhenxiong Huang, Qingqiang Lu, Ying Chen, Xiaohong Luo, Guoxun Chen, Yun Luo, Furong Bai, Songlin Wang, Yanhong Wang, Xiaojin Peng
  • Methods and compositions for STAT-1 conferred resistance to immunotoxicity
    Publication number: 20020141979
    Abstract: The present invention describes methods and compositions for preventing immuno-cytotoxicity of transplanted cells. The invention provides cells and expression constructs encoding STAT-1&agr; polypeptides that prevent cytokine-mediated cytotoxicity. Thus, the invention provides treatment methods for preventing the rejection of transplanted cells by a host. In a particular embodiment, the invention provides for treatment of diabetes by transplanting into a subject insulinoma cells that secrete insulin in response to glucose and further express STAT-1&agr;, thereby conferring resistance to inflammatory cytokines involved in the cell-rejection response.
    Type: Application
    Filed: April 10, 2001
    Publication date: October 3, 2002
    Inventors: Guoxun Chen, Christopher B. Newgard
  • Methods and compositions relating to no-mediated cytotoxicity
    Patent number: 6171856
    Abstract: The present invention relates to methods and compositions for the treatment of diabetes involving free radicals. In particular, the present invention is directed to the treatment or prophylactic intervention of diabetes. The present invention demonstrates that MnSOD can play a protective role against cytokine killing, and provides strategies for engineering cell lines as islet surrogates for transplantation therapy of diabetes mellitus. Further, the present invention shows that &bgr;-cell destruction and dysfunction in adipogenic diabetes is mediated via fatty acids. Methods and compositions for ameliorating this disorder are provided herein.
    Type: Grant
    Filed: July 30, 1998
    Date of Patent: January 9, 2001
    Assignees: Board of Regents, The University of Texas System, Betagene, Inc
    Inventors: Anice Thigpen, Hans-Ewald Hohmeier, Christopher B. Newgard, Roger H. Unger, Michio Shimabukuro, Guoxun Chen, Christopher J. Rhodes, Sigrun R. H{umlaut over (u)}gl, Sharon Cousin